Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q7L211
UPID:
ABHDD_HUMAN
Alternative names:
Alpha/beta hydrolase domain-containing protein 13
Alternative UPACC:
Q7L211; B3KWE7; Q8NBW1; Q96JX9
Background:
Protein ABHD13, also known as Alpha/beta hydrolase domain-containing protein 13, plays a crucial role in cellular processes through its enzymatic activities. The specific functions of ABHD13 remain to be fully elucidated, yet its presence across various tissues suggests a fundamental role in human biology.
Therapeutic significance:
Understanding the role of Protein ABHD13 could open doors to potential therapeutic strategies. Its involvement in essential cellular functions hints at the possibility of targeting ABHD13 for the treatment of diseases, once its disease associations are better understood.